Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers
Open Access
- 5 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 40 (14), 2496-2508
- https://doi.org/10.1038/s41388-021-01710-y
Abstract
Targeting PARP1 [Poly(ADP-Ribose) Polymerase 1] for synthetic lethality is a new strategy for BRCA germ-line mutated or platinum sensitive ovarian cancers. However, not all patients respond due to intrinsic or acquired resistance to PARP1 inhibitor. Development of alternative synthetic lethality approaches is a high priority. DNA polymerase β (Polβ), a critical player in base excision repair (BER), interacts with PARP1 during DNA repair. Here we show that polβ deficiency is a predictor of platinum sensitivity in human ovarian tumours. Polβ depletion not only increased platinum sensitivity but also reduced invasion, migration and impaired EMT (epithelial to mesenchymal transition) of ovarian cancer cells. Polβ small molecular inhibitors (Pamoic acid and NSC666719) were selectively toxic to BRCA2 deficient cells and associated with double-strand breaks (DSB) accumulation, cell cycle arrest and increased apoptosis. Interestingly, PARG [Poly(ADP-Ribose) Glycohydrolase] inhibitor (PDD00017273) [but not PARP1 inhibitor (Olaparib)] was synthetically lethal in polβ deficient cells. Selective toxicity to PDD00017273 was associated with poly (ADP-ribose) accumulation, reduced nicotinamide adenine dinucleotide (NAD+) level, DSB accumulation, cell cycle arrest and increased apoptosis. In human tumours, polβ-PARG co-expression adversely impacted survival in patients. Our data provide evidence that polβ targeting is a novel strategy and warrants further pharmaceutical development in epithelial ovarian cancers.Keywords
This publication has 56 references indexed in Scilit:
- Mammalian Base Excision Repair: the Forgotten ArchangelNucleic Acids Research, 2013
- DNA Polymerase β as a Novel Target for Chemotherapeutic Intervention of Colorectal CancerPLOS ONE, 2011
- A Novel Inhibitor of DNA Polymerase β Enhances the Ability of Temozolomide to Impair the Growth of Colon Cancer CellsMolecular Cancer Research, 2009
- A platinum agent resistance gene, POLB, is a prognostic indicator in colorectal cancerJournal of Surgical Oncology, 2009
- Structural insights on the pamoic acid and the 8 kDa domain of DNA polymerase beta complex: Towards the design of higher-affinity inhibitorsBMC Structural Biology, 2008
- Poly(ADP-Ribose) Polymerase 1 Accelerates Single-Strand Break Repair in Concert with Poly(ADP-Ribose) GlycohydrolaseMolecular and Cellular Biology, 2007
- Human base excision repair complex is physically associated to DNA replication and cell cycle regulatory proteinsNucleic Acids Research, 2007
- Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell deathProceedings of the National Academy of Sciences of the United States of America, 2006
- Poly(ADP-ribose) (PAR) polymer is a death signalProceedings of the National Academy of Sciences of the United States of America, 2006
- Reconstitution of the DNA base excision—repair pathwayCurrent Biology, 1994